NCT05126160View on ClinicalTrials.gov

Immune Score Based Radiomics in Nasopharyngeal Carcinoma

RecruitingOBSERVATIONAL
Enrollment

494

Participants

Timeline

Start Date

November 5, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2027

Conditions
Nasopharyngeal Carcinoma
Interventions
DIAGNOSTIC_TEST

Immune Score Based Radiomics

To establish an immune score based radiomic staging system for nasopharyngeal carcinoma

Trial Locations (5)

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

315000

RECRUITING

Ningbo First Hospital, Ningbo

RECRUITING

Ningbo Medical Center Lihuili Hospital, Ningbo

325000

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

430060

RECRUITING

Renmin Hospital of Wuhan University, Wuhan

All Listed Sponsors
collaborator

Renmin Hospital of Wuhan University

OTHER

collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

Ningbo Medical Center Lihuili Hospital

OTHER_GOV

collaborator

Ningbo No. 1 Hospital

OTHER

lead

Zhejiang Cancer Hospital

OTHER

NCT05126160 - Immune Score Based Radiomics in Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter